Thomas McCauley

Insider Reports History

Entity
Individual
Location
C/O Omega Therapeutics, Inc., 20 Acorn Park D, Cambridge, MA
Signature
/s/ Barbara Chan as Attorney-in-Fact for Thomas McCauley
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas McCauley:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Omega Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 75K Feb 7, 2024 Direct

Insider Reports Filed by Thomas McCauley

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OMGA Omega Therapeutics, Inc. Feb 7, 2024 2 $0 4 Feb 9, 2024 Chief Scientific Officer
OMGA Omega Therapeutics, Inc. Feb 28, 2023 1 $0 4 Mar 2, 2023 Chief Scientific Officer
OMGA Omega Therapeutics, Inc. Oct 27, 2022 1 $0 4 Oct 28, 2022 Chief Scientific Officer
OMGA Omega Therapeutics, Inc. Mar 9, 2022 1 $0 4 Mar 11, 2022 Chief Scientific Officer
OMGA Omega Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 Chief Scientific Officer